Lung Cancer Clinical Trial

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Summary

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. Conduct a randomized, controlled trial evaluating the efficacy of a conversation tool on patient-centered health and decision-making outcomes among patients making lung cancer treatment decisions. A subset of participants from control and intervention groups will also have their clinic conversations with providers recorded II. Conduct in-depth, semi-structured qualitative audio or video recorded interviews among a subset of Aim 1 participants.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients review decision aid.

GROUP II: Patients receive standard of care.

After completion of study intervention, patients are followed up at 2 weeks, 3 months, and 6 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

AIM 1: Suspected lung cancer
AIM 1: English fluency
AIM 1: > 6-month life expectancy
AIM 1: Score of ≥ 3 on the cognitive impairment screener
AIM 2 PARTICIPANTS: Participation in Aim 1
AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Study is for people with:

Lung Cancer

Estimated Enrollment:

300

Study ID:

NCT05407168

Recruitment Status:

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Hillsboro Medical Center
Hillsboro Oregon, 97123, United States More Info
Donald Sullivan, MD, MA, MCR
Contact
503-220-8262
[email protected]
Donald Sullivan, MD, MA, MCR
Principal Investigator
Adventist Health Portland
Portland Oregon, 97216, United States More Info
Donald Sullivan, MD, MA, MCR
Contact
503-220-8262
[email protected]
Donald Sullivan, MD, MA, MCR
Principal Investigator
OHSU Knight Cancer Institute
Portland Oregon, 97239, United States More Info
Donald R Sullivan, MD, MA, MCR
Contact
503-220-8262
[email protected]
Donald R Sullivan, MD, MA, MCR
Principal Investigator
Portland VA Medical Center
Portland Oregon, 97239, United States More Info
Donald R Sullivan, MD, MA, MCR
Contact
503-220-8262
[email protected]
Donald R Sullivan, MD, MA, MCR
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

300

Study ID:

NCT05407168

Recruitment Status:

Recruiting

Sponsor:


OHSU Knight Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.